Diet pattern and adequacy
Foods · energy · fiber · variety · accessA single nutrient cannot summarize the quality, feasibility, culture, or sustainability of an eating pattern.
EN|PTMERHI ONE — NUTRITION & SUPPLEMENTS
Understand food patterns, nutrients, supplements, studied indications, doses, interactions, product quality, and uncertainty—without turning every symptom into a deficiency.
The nutrition map
Nutrition begins with dietary pattern and context. A supplement only becomes a responsible question after need, evidence, dose, safety, and product quality are considered.
A single nutrient cannot summarize the quality, feasibility, culture, or sustainability of an eating pattern.
Protein and creatine answer different questions. Benefits depend on the population, outcome, training, baseline intake, and safety context.
Laboratory values, symptoms, diet, absorption, medicines, life stage, and disease can change whether supplementation is useful or risky.
These are not one category of benefit. Each indication needs its own outcomes, evidence rating, dose range, interaction review, and regulatory context.
A studied dose is not automatically a personal prescription. The decision should define what is being treated, what will be measured, and when to reconsider.
More is not better. Ingredient identity, formulation, total dose, third-party testing, prohibited claims, and adverse-event pathways matter.
MERHI ONE method
Every article follows the same sequence so evidence, uncertainty, and safety remain visible.
What is the dietary pattern, life stage, clinical context, and baseline intake?
Which defined indication and outcome are being considered?
What do guidelines, systematic reviews, trials, and official sources actually support?
Which forms, doses, and durations were studied—and in whom?
Which adverse effects, interactions, contraindications, and monitoring needs matter?
Does the label identify the ingredient, amount, serving, claims, and quality signals clearly?
Evidence Rating
This is the unit of evaluation. Magnesium for correcting documented deficiency is not the same claim as magnesium for sleep, anxiety, cramps, migraine, blood pressure, or broad ‘wellness.’
Supplements generally reach the market without FDA preapproval for safety and effectiveness. Label reading, adverse-event reporting, and quality verification are essential.
ANVISA defines authorized constituents, use limits, warnings, and permitted claims. Legal sale does not prove benefit for every advertised purpose.
Published core
Editorial sequence
Each will become an individual bilingual page with claim-level evidence ratings, safety, references, and Brazil–U.S. localization.
Scientific and regulatory foundation
Individual articles will add indication-specific guidelines, systematic reviews, randomized trials, limitations, and review dates.
NIH Office of Dietary Supplements · current
U.S. Food and Drug Administration · 2026
Dietary Guidelines for Americans · 2025–2030
Agência Nacional de Vigilância Sanitária · current
Agência Nacional de Vigilância Sanitária · current
Ministério da Saúde do Brasil · current
Editorial record